Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt, Duke, and Novartis Study Proteomics of Heart Disease

NEW YORK, Sept. 4-Researchers at GeneProt and Novartis are working with cardiologists at Duke University Medical Center to characterize distinctive protein expression patterns in heart disease patients, the university said yesterday.


The researchers are using an "industrial-scale" approach to protein analysis in order to uncover the subtle differences between protein levels in healthy people and people with coronary artery disease.


Duke has identified appropriate patients and provided access to clinical samples through its large database of cardiovascular patients. GeneProt is analyzing proteins of interest, and synthesizing some of them for further study by researchers at Novartis.


The collaborators have identified 106 matched healthy controls and heart disease patients, and plan to analyze a total of six liters of blood from each group. These large volumes of blood are necessary, according to the researchers, in order to accurately identify proteins relevant to disease.


At Duke, the study is led by Chris Granger, a cardiologist at the university's clinical research institute.


For further information, see the press release.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.